PROCEPT BioRobotics (PRCT) Total Non-Current Liabilities (2020 - 2026)

PROCEPT BioRobotics (PRCT) has 7 years of Total Non-Current Liabilities data on file, last reported at $139.3 million in Q1 2026.

• Quarterly Total Non-Current Liabilities rose 7.22% year-over-year to $139.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $139.3 million (up 7.22% YoY) and the FY2025 annual result came in at $142.1 million, up 8.06% from the prior year.
• Total Non-Current Liabilities declined to $139.3 million in Q1 2026 per PRCT's latest filing, from $142.1 million in the prior quarter.
• Across five years, Total Non-Current Liabilities topped out at $142.1 million in Q4 2025 and bottomed at $68.0 million in Q1 2022.
• The 5-year median for Total Non-Current Liabilities is $122.1 million (2024), against an average of $117.2 million.
• The widest annual swing landed in 2022, when Total Non-Current Liabilities jumped 61.43%; it then retreated 1.33% in 2025.
• Tracing PRCT's Total Non-Current Liabilities over 5 years: stood at $110.5 million in 2022, then advanced by 11.74% to $123.4 million in 2023, then increased by 6.5% to $131.5 million in 2024, then increased by 8.06% to $142.1 million in 2025, then dropped by 1.96% to $139.3 million in 2026.
• Per Business Quant, the three latest PRCT Total Non-Current Liabilities figures stand at $139.3 million (Q1 2026), $142.1 million (Q4 2025), and $130.7 million (Q3 2025).

Peer Comparison